Medigene AG appointed Dr Selwyn Ho as new Chief Executive Officer (CEO) of Medigene with effect of 25 July 2022. He accepted the appointments. As a consequence, Prof. Dolores Schendel will step down as Chief Executive Officer at the end of 24 July 2022 and fully focus on her responsibilities as Chief Scientific Officer (CSO) and Head of Research and Development at Medigene.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 EUR | -2.16% | -6.58% | -25.57% |
06-27 | Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness | CI |
05-21 | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.57% | 35.85M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene Ag Announces Executive Changes